Evidence map›Paper›PMID 20463941›Full record

ReviewInternational journal of nanomedicine2010

Biomimetic nanoparticles: preparation, characterization and biomedical applications.

Ana Maria Carmona-Ribeiro

Abstract readReview
In one paragraph

Review in International journal of nanomedicine, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Emerging Cationic Nanovaccines.Pharmaceutics · 2024
    Review
  5. Review
  6. Review
  7. Virosome: An engineered virus for vaccine delivery.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2023
    Review
  8. Review
  9. Review
  10. Article
  11. Novel Proteoliposome-Based Vaccine againstAnimals : an open access journal from MDPI · 2022
    Article
  12. Article
  13. Review
  14. Supramolecular Nanostructures for Vaccines.Biomimetics (Basel, Switzerland) · 2021
    Review
  15. Article
  16. Antimicrobial Polymer-Based Assemblies: A Review.International journal of molecular sciences · 2021
    Review
  17. Immunogenicity of antigens from outer membrane vesicles ofClinical and experimental vaccine research · 2021
    Article
  18. Article
  19. Article
  20. Cationic Nanostructures for Vaccines Design.Biomimetics (Basel, Switzerland) · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Ana Maria Carmona-RibeiroBiocolloids Lab, Departamento de Bioquímica, Instituto de Química, Universidade de São Paulo, São Paulo, Brazil. amcr@usp.br

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mimicking nature is a powerful approach for developing novel lipid-based devices for drug and vaccine delivery. In this review, biomimetic assemblies based on natural or synthetic lipids by themselves or associated to silica, latex or drug particles will be discussed. In water, self-assembly of lipid molecules into supramolecular structures is fairly well understood. However, their self-assembly on a solid surface or at an interface remains poorly understood. In certain cases, hydrophobic drug granules can be dispersed in aqueous solution via lipid adsorption surrounding the drug particles as nanocapsules. In other instances, hydrophobic drug molecules attach as monomers to borders of lipid bilayer fragments providing drug formulations that are effective in vivo at low drug-to-lipid-molar ratio. Cationic biomimetic particles offer suitable interfacial environment for adsorption, presentation and targeting of biomolecules in vivo. Thereby antigens can effectively be presented by tailored biomimetic particles for development of vaccines over a range of defined and controllable particle sizes. Biomolecular recognition between receptor and ligand can be reconstituted by means of receptor immobilization into supported lipidic bilayers allowing isolation and characterization of signal transduction steps.

Indexed as

Biomimetic MaterialsDrug CarriersNanomedicineNanoparticlesDrug Carriersantigensbilayer fragmentscationic lipiddrugsnovel cationic immunoadjuvantsphospholipidspolymeric particlessilicavesicles

Identifiers

PMID20463941
PMCPMC2865020

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.